DexCom, Inc. - Common Stock (DXCM)
80.77
-8.29 (-9.31%)
NASDAQ · Last Trade: Jul 31st, 11:43 PM EDT
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
Via Benzinga · July 31, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · July 31, 2025
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.
Via Chartmill · July 31, 2025
Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s revenue to be around $4.61 billion, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 7.8% above analysts’ consensus estimates.
Via StockStory · July 30, 2025
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.
Via Chartmill · July 30, 2025
Dexcom stock fell late Wednesday after it reported Q2 earnings that topped expectations and named a new chief executive officer.
Via Investor's Business Daily · July 30, 2025
Medical device company DexCom (NASDAQ:DXCM)
will be reporting results this Wednesday after market hours. Here’s what to look for.
Via StockStory · July 28, 2025
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
Via StockStory · July 25, 2025
DexCom (DXCM) is a top growth stock with strong fundamentals, solid profitability, and bullish technical breakout signals, making it a compelling investment opportunity.
Via Chartmill · July 24, 2025
Via The Motley Fool · July 20, 2025
An update on Sana Biotechnology.
Via Benzinga · July 14, 2025
DEXCOM INC (NASDAQ:DXCM) shows a strong technical setup with positive trends, consolidation, and institutional interest, making it a breakout candidate for traders.
Via Chartmill · July 11, 2025
In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence.
These cash-heavy companies shine bright for their financial discipline, resilience, and ability to generate solid returns.
Via StockStory · July 3, 2025
DEXCOM INC (NASDAQ:DXCM) shows strong growth fundamentals and a promising technical setup, making it a stock to watch for breakout potential in the medical device sector.
Via Chartmill · July 2, 2025
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.
Via Investor's Business Daily · July 1, 2025
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via Chartmill · July 1, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via Chartmill · July 1, 2025
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · June 26, 2025
Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom.
Via Stocktwits · June 25, 2025